JP2002121110A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JP2002121110A JP2002121110A JP2000312429A JP2000312429A JP2002121110A JP 2002121110 A JP2002121110 A JP 2002121110A JP 2000312429 A JP2000312429 A JP 2000312429A JP 2000312429 A JP2000312429 A JP 2000312429A JP 2002121110 A JP2002121110 A JP 2002121110A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- cosmetic
- genus
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 44
- 241000196324 Embryophyta Species 0.000 claims abstract description 22
- 241000233930 Pandanus Species 0.000 claims abstract description 11
- 235000005308 Pandanus Nutrition 0.000 claims abstract description 11
- 108091074665 OCTOPUS family Proteins 0.000 claims description 2
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 10
- 208000003351 Melanosis Diseases 0.000 abstract description 3
- 241000233929 Pandanaceae Species 0.000 abstract 1
- 238000004061 bleaching Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- -1 jojoba oil Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 230000019612 pigmentation Effects 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 239000000843 powder Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 11
- 241000238413 Octopus Species 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 230000002087 whitening effect Effects 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 8
- 229960004705 kojic acid Drugs 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000013040 bath agent Substances 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001522723 Conoidea Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000006802 Pandanus sp Nutrition 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HRBSSAKLPZCBPP-LICCNWEZSA-N (2r)-3,4-dihydroxy-2-[(1s)-2-hydroxy-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-2h-furan-5-one Chemical compound O([C@@H](CO)[C@@H]1C(=C(O)C(=O)O1)O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HRBSSAKLPZCBPP-LICCNWEZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000006353 Pandanus amaryllifolius Species 0.000 description 1
- 244000079565 Pandanus andamanensium Species 0.000 description 1
- 244000265205 Pandanus boninensis Species 0.000 description 1
- 240000002390 Pandanus odoratissimus Species 0.000 description 1
- 244000114480 Pandanus utilis Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 231100000905 neutral red uptake (NRU) test Toxicity 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚に対してすぐ
れた美白・美肌化作用を示し、基礎化粧料をはじめ、メ
イクアップ化粧料、浴用剤などとして有用な化粧料に関
する。TECHNICAL FIELD The present invention relates to cosmetics which exhibit excellent skin whitening and skin whitening effects on the skin and are useful as basic cosmetics, makeup cosmetics, bath agents and the like.
【0002】[0002]
【従来の技術】日焼け或いは加齢に伴って生ずる色素沈
着、特にシミ、ソバカスを予防或いは症状改善し、皮膚
を美麗かつ健常な状態に保持することを目的として、従
来より種々の美白剤が提案され、それらを配合した化粧
料が上市されている。しかしながら、それら従来の美白
剤によっては、美白・美肌化効果と皮膚安全性の双方を
十分満足せしめることは困難であり、かかる点の改善さ
れた美白剤を有効成分として含む新規な化粧料が求めら
れている。2. Description of the Related Art Various whitening agents have been proposed for the purpose of preventing or improving pigmentation, particularly spots and freckles caused by aging or aging, and keeping the skin beautiful and healthy. And cosmetics containing them are on the market. However, with these conventional whitening agents, it is difficult to sufficiently satisfy both of the whitening / beautifying effect and the skin safety, and a new cosmetic containing such an improved whitening agent as an active ingredient is required. Have been.
【0003】[0003]
【発明が解決しようとする課題】本発明者らは、かかる
従来技術の問題点に鑑み、皮膚安全性の観点から天然物
由来の新たな美白有効成分を見出すべく鋭意研究を行っ
た結果、後記特定の植物の抽出物が顕著なチロシナーゼ
活性抑制作用を示し、これによって美白・美肌化効果と
皮膚安全性にすぐれた化粧料の提供が可能となることを
見出し、本発明を完成した。In view of the above problems of the prior art, the present inventors have conducted intensive studies to find new whitening active ingredients derived from natural products from the viewpoint of skin safety. The present inventors have found that an extract of a specific plant exhibits a remarkable tyrosinase activity-inhibiting action, thereby making it possible to provide a cosmetic having an excellent whitening / beautifying effect and excellent skin safety, and completed the present invention.
【0004】[0004]
【課題を解決するための手段】即ち本発明は、タコノキ
科タコノキ属に属する植物の抽出物を配合したことを特
徴とする化粧料である。That is, the present invention relates to a cosmetic comprising an extract of a plant belonging to the genus Taconium, which belongs to the genus Taconidae.
【0005】以下、本発明について詳細に説明する。本
発明で用いるタコノキ科タコノキ属の植物としては、例
えばパンダヌス・アマリリフォリウス(Pandanus amary
llifolius Roxb.)、パンダヌス・アンダマネンジウム
(P. andamanensium Kurz.)、パンダヌス・ボニネンシ
ス(P. boninensis Weber.)、パンダヌス・コノイデア
(P. conoidea Lamck.)、パンダヌス・エデュリス(P. e
dulis Thouars.)、パンダヌス・カフー(P. kafu Mar
t.)、パンダヌス・オードラス(P. odorus Ridl.)、パン
ダヌス・テクトリウス(P. tectorius Soland.)、パンダ
ヌス・アティリス(P. utilis Bory.)などが挙げられ
る。それらのうちでも、有効性の観点からパンダヌス・
アマリリフォリウスの使用が特に好ましい。Hereinafter, the present invention will be described in detail. Examples of the plants belonging to the genus Taconidaceae used in the present invention include, for example, Pandanus amariforius (Pandanus amary)
llifolius Roxb.), P. andamanensium Kurz., P. boninensis Weber., Pandanus conoidea.
(P. conoidea Lamck.), Pandanus Edulis (P. e
dulis Thouars.), P. kafu Mar
t.), P. odorus Ridl., P. tectorius Soland., P. utilis Bory., and the like. Among them, from the viewpoint of effectiveness, Pandanus
The use of Amariliforius is particularly preferred.
【0006】それらのタコノキ属植物の抽出物の調製
は、全草、葉、茎、根、種子など植物体の適宜の部分、
好ましくは葉を用い、一般にはこれを予め水洗、乾燥、
細切した上、抽出溶媒中に浸漬すること等によって行わ
れる。ここで抽出溶媒としては、水;メタノール、エタ
ノール、プロパノールなどの低級アルコール類;エチレ
ングリコール、プロピレングリコール、1、3−ブチレ
ングリコール、グリセリンなどの多価アルコール類;酢
酸エチル、酢酸ブチル、プロピオン酸メチルなどのエス
テル類;アセトン、メチルエチルケトンなどのケトン
類;エチルエーテル、イソプロピルエーテルなどのエー
テル類;n−ヘキサン、トルエン、クロロホルムなどの
炭化水素系溶媒などがあり、それらのうちでも特に水又
は水と低級アルコール類との混液もしくは水と多価アル
コール類との混液の使用が好ましい。[0006] The preparation of the extracts of the plants of the genus Octopus can be performed by preparing appropriate parts of the plant such as whole plants, leaves, stems, roots and seeds;
Preferably, leaves are used, and this is generally washed with water, dried,
It is carried out by slicing and immersing in an extraction solvent. Examples of the extraction solvent include water; lower alcohols such as methanol, ethanol, and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin; ethyl acetate, butyl acetate, and methyl propionate. Esters such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as n-hexane, toluene and chloroform, among which water or water and lower grades are particularly preferred. It is preferable to use a mixture of alcohols or a mixture of water and polyhydric alcohols.
【0007】抽出温度、時間は、用いた植物の種類、細
切度、抽出溶媒の種類等によっても異なるが、一般には
5〜80℃で2時間〜7日間、特に20〜40℃で6〜
48時間抽出を行うのがよい。ここに得られる抽出物溶
液は、通常pHを4〜8に調整した上、そのままもしく
は減圧濃縮等により適宜の濃度として使用される。また
場合によっては、スプレードライ法、凍結乾燥法など常
法に従って粉末化して使用してもよい。The extraction temperature and time vary depending on the type of plant used, the degree of shredding, the type of extraction solvent, etc., but are generally from 5 to 80 ° C. for 2 hours to 7 days, especially from 20 to 40 ° C. for 6 to 6 days.
It is preferable to perform the extraction for 48 hours. The extract solution obtained here is usually adjusted to a pH of 4 to 8, and then used as it is or at an appropriate concentration by vacuum concentration or the like. In some cases, the powder may be used in the form of powder according to a conventional method such as a spray drying method or a freeze drying method.
【0008】本発明の化粧料中に於ける上記の抽出物の
配合量は、固形分濃度として、クリーム、乳液、ローシ
ョンなどの基礎化粧料の場合であれば、一般に0.001〜
0.5重量%、好ましくは0.01〜0.1重量%の範囲、またほ
ほ紅、白粉などのメイクアップ化粧料の場合であれば、
一般に0.001〜0.5重量%、好ましくは0.01〜0.1重量%
の範囲であり、浴用剤の場合であれば、一般に0.01〜5
重量%、好ましくは0.1〜1重量%の範囲である。[0008] The amount of the above-mentioned extract in the cosmetic of the present invention is generally 0.001 to 0.003 as solid content in the case of basic cosmetics such as creams, emulsions and lotions.
0.5% by weight, preferably in the range of 0.01 to 0.1% by weight, and in the case of makeup cosmetics such as blush, white powder,
Generally 0.001 to 0.5% by weight, preferably 0.01 to 0.1% by weight
In the case of a bath agent, generally 0.01 to 5
%, Preferably in the range of 0.1 to 1% by weight.
【0009】本発明の化粧料には、必須成分のタコノキ
属植物抽出物のほかに、通常化粧料に用いられる成分、
例えば油性成分、界面活性剤、保湿剤、増粘剤、防腐・
殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、色素、香
料等が必要に応じて適宜配合される。The cosmetic of the present invention contains, in addition to the extract of the plant belonging to the genus Taconium, an ingredient commonly used in cosmetics,
For example, oily components, surfactants, humectants, thickeners, preservatives
A bactericide, a powder component, an ultraviolet absorber, an antioxidant, a dye, a fragrance and the like are appropriately compounded as required.
【0010】ここで、油性成分としては、例えばオリー
ブ油、ホホバ油、ヒマシ油、大豆油、ヤシ油、パーム
油、カカオ油、メドウホーム油などの植物由来の油脂
類;ミンク油、タートル油などの動物由来の油脂類;ミ
ツロウ、カルナウバロウ、ラノリンなどのロウ類;流動
パラフィン、ワセリン、パラフィンワックス、スクワラ
ンなどの炭化水素類;ミリスチン酸、パルミチン酸、ス
テアリン酸、オレイン酸、イソステアリン酸などの脂肪
酸類;ラウリルアルコール、セタノール、ステアリルア
ルコールなどの高級アルコール類;ミリスチン酸イソプ
ロピル、オレイン酸ブチル、2−エチルヘキシルグリセ
ライドなどの合成エステル類及び合成トリグリセライド
類等が挙げられる。Here, the oily component includes, for example, plant-derived oils and fats such as olive oil, jojoba oil, castor oil, soybean oil, coconut oil, palm oil, cacao oil, and meadow home oil; mink oil, turtle oil and the like. Animal-derived fats and oils; waxes such as beeswax, carnauba wax and lanolin; hydrocarbons such as liquid paraffin, vaseline, paraffin wax and squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid; Higher alcohols such as lauryl alcohol, cetanol and stearyl alcohol; synthetic esters such as isopropyl myristate, butyl oleate, and 2-ethylhexyl glyceride; and synthetic triglycerides.
【0011】界面活性剤としては、例えばポリオキシエ
チレンアルキルエーテル、ポリオキシエチレン脂肪酸エ
ステル、ポリオキシエチレンソルビタン脂肪酸エステ
ル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸
エステル、ポリオキシエチレングリセリン脂肪酸エステ
ル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチ
レンソルビトール脂肪酸エステルなどの非イオン界面活
性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンス
ルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸
塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシ
エチレンアルキルフェニルエーテル硫酸塩、ポリオキシ
エチレンアルキルエーテル燐酸塩、α−スルホン化脂肪
酸アルキルエステル塩、ポリオキシエチレンアルキルフ
ェニルエーテル燐酸塩などのアニオン界面活性剤;第四
級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリ
アルキルベンジルアンモニウム塩、アルキルピリジニウ
ム塩、2−アルキル−1−アルキル−1−ヒドロキシエ
チルイミダゾリニウム塩、N、N−ジアルキルモルフォ
ルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩な
どのカチオン界面活性剤;N、N−ジメチル−N−アル
キル−N−カルボキシメチルアンモニオベタイン、N、
N、N−トリアルキル−N−アルキレンアンモニオカル
ボキシベタイン、N−アシルアミドプロピル−N′、
N′−ジメチル−N′−β−ヒドロキシプロピルアンモ
ニオスルホベタインなどの両性界面活性剤等が挙げられ
る。Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, and polyoxyethylene cured castor. Non-ionic surfactants such as oils and polyoxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkyl benzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ethers Sulfate, polyoxyethylene alkyl ether phosphate, α-sulfonated fatty acid alkyl ester salt, polyoxyethylene alkyl phenyl ether phosphate Quaternary ammonium salts, primary to tertiary fatty amine salts, trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts , N, N-dialkylmorphonium salts, cationic surfactants such as polyethylenepolyamine fatty acid amide salts; N, N-dimethyl-N-alkyl-N-carboxymethylammonio betaine;
N, N-trialkyl-N-alkyleneammoniocarboxybetaine, N-acylamidopropyl-N ',
And amphoteric surfactants such as N'-dimethyl-N'-β-hydroxypropylammoniosulfobetaine.
【0012】保湿剤としては、例えばグリセリン、プロ
ピレングリコール、ジプロピレングリコール、1、3−
ブチレングリコール、ポリエチレングリコール、ソルビ
トール、キシリトール、ピロリドンカルボンナトリウム
等があり、さらに糖類、ヒアルロン酸、乳酸、尿素、高
級脂肪酸オクチルドデシル、各種アミノ酸及びそれらの
誘導体が挙げられる。Examples of humectants include glycerin, propylene glycol, dipropylene glycol, 1,3-
Examples include butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and further include saccharides, hyaluronic acid, lactic acid, urea, higher fatty acid octyldodecyl, various amino acids, and derivatives thereof.
【0013】増粘剤としては、例えばカラギーナン、ア
ルギン酸、ペクチン、ローカストビーンガムなどの多糖
類;キサンタンガム、トラガカントガム、グアーガムな
どのガム類;カルボキシメチルセルロース、ヒドロキシ
エチルセルロースなどのセルロース誘導体;ポリビニル
アルコール、ポリビニルピロリドン、カルボキシビニル
ポリマー、アクリル酸・メタクリル酸共重合体などの合
成高分子類;ヒアルロン酸及びその誘導体等が挙げられ
る。Examples of the thickener include polysaccharides such as carrageenan, alginic acid, pectin, and locust bean gum; gums such as xanthan gum, tragacanth gum and guar gum; cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; polyvinyl alcohol, polyvinyl pyrrolidone; Synthetic polymers such as carboxyvinyl polymer and acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives;
【0014】防腐殺菌剤としては、例えば尿素;パラオ
キシ安息香酸メチル、パラオキシ安息香酸エチル、パラ
オキシ安息香酸プロピル、パラオキシ安息香酸ブチルな
どのパラオキシ安息香酸エステル類;フェノキシエタノ
ール、ジクロロフェン、ヘキサクロロフェン、塩酸クロ
ルヘキシジン、塩化ベンザルコニウム、サリチル酸、エ
タノール、ウンデシレン酸、フェノール類、ジャマール
(イミダゾデイニールウレア)等がある。Examples of preservative disinfectants include urea; paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate and butyl paraoxybenzoate; phenoxyethanol, dichlorophen, hexachlorophen, chlorhexidine hydrochloride, Examples include benzalkonium chloride, salicylic acid, ethanol, undecylenic acid, phenols, and jamal (imidazodeinyl urea).
【0015】粉体成分としては、例えばセリサイト、酸
化チタン、タルク、カオリン、ベントナイト、酸化亜
鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコ
ニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパ
ウダー等がある。Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder and the like.
【0016】紫外線吸収剤としては、例えばパラアミノ
安息香酸エチル、パラジメチルアミノ安息香酸エチルヘ
キシル、サリチル酸アミル及びその誘導体、パラメトキ
シ桂皮酸エチルヘキシル、桂皮酸オクチル、2、4−ジ
ヒドロキシベンゾフェノン、2−ヒドロキシ−4−メト
キシベンゾフェノン−5−スルホン酸塩、2−(2−ヒ
ドロキシ−5−メチルフェニル)ベンゾトリアゾール、
ウロカニン酸、ウロカニン酸エチル等がある。Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, ethylhexyl paramethoxycinnamate, octyl cinnamate, 2,4-dihydroxybenzophenone, 2-hydroxy-4- Methoxybenzophenone-5-sulfonate, 2- (2-hydroxy-5-methylphenyl) benzotriazole,
There are urocanic acid, ethyl urocanate and the like.
【0017】抗酸化剤としては、例えばブチルヒドロキ
シアニソール、ブチルヒドロキシトルエン、没食子酸プ
ロピル、ビタミンE及びその誘導体等がある。又、その
他の成分として、レシチン類、シルク関連物質等を配合
することもできる。Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof. Further, as other components, lecithins, silk-related substances and the like can be blended.
【0018】本発明の化粧料には、本発明の組み合わせ
成分の有効性を損なわない範囲で、さらに他の生理活性
成分を配合してもよい。かかるものとしては、例えばコ
ウジ酸及びその誘導体(例えば、コウジ酸モノブチレー
ト、コウジ酸モノカプレート、コウジ酸モノパルミテー
ト、コウジ酸ジブチレートなどのコウジ酸エステル類或
いはコウジ酸エーテル類等)、アルブチン、アスコルビ
ン酸及びその誘導体[例えば、L−アスコルビン酸−2
−リン酸エステル塩、L−アスコルビン酸−2−硫酸エ
ステル塩などのアスコルビン酸エステル塩類(塩はナト
リウム塩、マグネシウム塩など);L−アスコルビン酸
−2−グルコシド(2−O−α−D−グルコピラノシル
−L−アスコルビン酸)、L−アスコルビン酸−5−グ
ルコシド(5−O−α−D−グルコピラノシル−L−ア
スコルビン酸)などのアスコルビン酸配糖体類等]、エ
ラグ酸、レゾルシノール誘導体(例えば、4−n−ブチ
ルレゾルシノール、4−イソアミルレゾルシノール
等)、ソウハクヒ抽出液、ユキノシタ抽出液、米糠抽出
物、2、5−ジヒドロキシ安息香酸誘導体(例えば2、
5−ジアセトキシ安息香酸等)などの美白成分;胎盤抽
出物、コラーゲン、ニコチン酸及びその誘導体(例えば
ニコチン酸アミド、ニコチン酸ベンジル等)、ビタミンE
及びその誘導体(例えばビタミンEニコチネート、ビタ
ミンEリノレート等)、α−ヒドロキシ酸類(例えば乳
酸、クエン酸、α−ヒドロキシオクタン酸等)、ジイソ
プロピルアミンジクロロアセテート、γ−アミノ−β−
ヒドロキシ酪酸などの皮膚老化防止・肌荒れ改善成分;
ゲンチアナエキスなどの生薬抽出エキス等がある。The cosmetic of the present invention may further contain other physiologically active ingredients as long as the effectiveness of the combination of the present invention is not impaired. Such compounds include, for example, kojic acid and its derivatives (eg, kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate, etc.) and arbutin, ascorbic acid Acids and derivatives thereof [for example, L-ascorbic acid-2
-Ascorbic acid ester salts such as phosphoric acid ester salt and L-ascorbic acid-2-sulfate ester salt (the salt is sodium salt, magnesium salt and the like); L-ascorbic acid-2-glucoside (2-O-α-D- Ascorbic acid glycosides such as glucopyranosyl-L-ascorbic acid) and L-ascorbic acid-5-glucoside (5-O-α-D-glucopyranosyl-L-ascorbic acid), ellagic acid, resorcinol derivatives (for example, , 4-n-butyl resorcinol, 4-isoamyl resorcinol, etc.), somaria extract, saxifrage extract, rice bran extract, 2,5-dihydroxybenzoic acid derivative (e.g., 2,
Whitening ingredients such as 5-diacetoxybenzoic acid); placental extract, collagen, nicotinic acid and its derivatives (eg, nicotinamide, benzyl nicotinate, etc.), vitamin E
And derivatives thereof (eg, vitamin E nicotinate, vitamin E linoleate, etc.), α-hydroxy acids (eg, lactic acid, citric acid, α-hydroxyoctanoic acid, etc.), diisopropylamine dichloroacetate, γ-amino-β-
Hydroxy lactic acid and other ingredients for preventing skin aging and improving skin roughness;
There are crude drug extracts such as gentian extract.
【0019】次に、製造例、実施例(処方例)及び試験例
によって本発明をさらに具体的に説明するが、本発明は
それらに限定されるものではない。なお、以下に於い
て、部はすべて重量部を、また%はすべて重量%を意味
する。Next, the present invention will be described more specifically with reference to Production Examples, Examples (Formulation Examples) and Test Examples, but the invention is not limited thereto. In the following, all parts are parts by weight, and all parts are by weight.
【0020】製造例1 タコノキ属植物抽出物溶液の調
製(1) パンダヌス・アマリリフォリウスの葉の乾燥物を約5m
mに細切したもの50gを、精製水500gに浸漬し、
十分攪拌した後室温に18時間静置した。次にこれをろ
過し、褐色透明の抽出物溶液350mlを得た(固形分
濃度:1.02%)。Production Example 1 Preparation of an extract solution of a plant belonging to the genus Octopus (1) Dried leaves of Pandanus amariliforius were about 5 m
m, and immersed in 500 g of purified water,
After sufficient stirring, the mixture was allowed to stand at room temperature for 18 hours. Next, this was filtered to obtain 350 ml of a brown transparent extract solution (solid content concentration: 1.02%).
【0021】製造例2 タコノキ属植物抽出物溶液の調
製(2) 製造例1に於いて、抽出溶媒として精製水の代わりに精
製水/エタノール=80/20(V/V)の混液を用い
るほかは製造例1と同様にして、褐色透明の抽出物溶液
380mlを得た(固形分濃度:0.65%)。Preparation Example 2 Preparation of an extract of a plant of the genus Octopus (2) In Preparation Example 1, a mixed solution of purified water / ethanol = 80/20 (V / V) was used instead of purified water as the extraction solvent. In the same manner as in Production Example 1, 380 ml of a brown transparent extract solution was obtained (solid content: 0.65%).
【0022】製造例3 タコノキ属植物抽出物溶液の調
製(3) 製造例1に於いて、タコノキ属植物としてパンダヌス・
アマリリフォリウスに代えてパンダヌス・テクトリウス
を用いるほかは製造例1と同様にして、褐色透明の抽出
物溶液350mlを得た(固形分濃度:1.00%)。Preparation Example 3 Preparation of an extract of a plant of the genus Taconium (3) In Preparation Example 1, Pandanus sp.
350 ml of a brown and transparent extract solution was obtained in the same manner as in Production Example 1 except that Pandanus techtolius was used instead of Amariliforius (solid content: 1.00%).
【0023】製造例4 タコノキ属植物抽出物溶液の調
製(4) 製造例1に於いて、タコノキ属植物としてパンダヌス・
アマリリフォリウスに代えてパンダヌス・アンダマネン
ジウムを用いるほかは製造例1と同様にして、褐色透明
の抽出物溶液360mlを得た(固形分濃度:0.95
%)。Preparation Example 4 Preparation of an extract of a plant of the genus Taconium (4) In Preparation Example 1, Pandanus sp.
360 ml of a brown transparent extract solution was obtained in the same manner as in Production Example 1 except that Pandanus andamanendium was used instead of Amariliforius (solid content: 0.95).
%).
【0024】製造例5 タコノキ属植物抽出物粉末の調
製 製造例1と同様にして得られた抽出物溶液を35mlに
濃縮した後凍結乾燥し、抽出物粉末3.5gを得た。Preparation Example 5 Preparation of powder extract of Aspergillus plant extract The extract solution obtained in the same manner as in Preparation Example 1 was concentrated to 35 ml and freeze-dried to obtain 3.5 g of extract powder.
【0025】 実施例1 クリーム [A成分] 部 流動パラフィン 5.0 ヘキサラン[(株)テクノーブル製トリオクタン酸グリセリル] 4.0 パラフィン 5.0 グリセリルモノステアレート 2.0 ポリオキシエチレン(20)ソルビタンモノステアレート 6.0 ブチルパラベン 0.1 [B成分] 製造例1の抽出物溶液 5.0 グリセリン 5.0 カルボキシメチルモノステアレート 0.1 メチルパラベン 0.1 モイストン・C[(株)テクノーブル製NMF成分] 1.0 精製水 全量が100部となる量 [C成分] 香料 適量 上記のA成分とB成分をそれぞれ80℃以上に加熱した
後、攪拌混合した。これを50℃まで冷却した後、C成
分を加えてさらに攪拌混合してクリームを調製した。Example 1 Cream [A component] part Liquid paraffin 5.0 hexalane [glyceryl trioctanoate manufactured by Technoble Co., Ltd.] 4.0 paraffin 5.0 glyceryl monostearate 2.0 polyoxyethylene (20) sorbitan Monostearate 6.0 Butylparaben 0.1 [Component B] Extract solution of Production Example 1 5.0 Glycerin 5.0 Carboxymethylmonostearate 0.1 Methylparaben 0.1 Moiston C [Technol Co., Ltd.] NMF Component] 1.0 Amount of purified water to make the total amount 100 parts [Component C] Perfume Appropriate Amount The above components A and B were each heated to 80 ° C. or higher, and then stirred and mixed. After cooling to 50 ° C., the C component was added and further stirred and mixed to prepare a cream.
【0026】 実施例2 乳液 [A成分] 部 流動パラフィン 6.0 ヘキサラン 4.0 ホホバ油 1.0 ポリオキシエチレン(20)ソルビタンモノステアレート 2.0 大豆レシチン 1.5 メチルパラベン 0.15 エチルパラベン 0.03 [B成分] 製造例2の抽出物溶液 2.5 グリセリン 3.0 1、3−ブチレングリコール 2.0 カルボキシメチルセルロース 0.3 ヒアルロン酸ナトリウム 0.01 精製水 全量が100部となる量 [C成分] 香料 適量 上記のA成分とB成分をそれぞれ80℃以上に加熱した
後、攪拌混合した。これを50℃まで冷却した後、C成
分を加えてさらに攪拌混合して乳液を調製した。Example 2 Emulsion [Component A] Part Liquid paraffin 6.0 Hexaran 4.0 Jojoba oil 1.0 Polyoxyethylene (20) sorbitan monostearate 2.0 Soybean lecithin 1.5 Methylparaben 0.15 Ethylparaben 0.03 [Component B] Extract solution of Production Example 2 2.5 Glycerin 3.0 1,3-butylene glycol 2.0 Carboxymethylcellulose 0.3 Sodium hyaluronate 0.01 Purified water Amount that makes the total amount 100 parts [Component C] Perfume Appropriate amount After heating the above components A and B to 80 ° C. or higher, they were mixed by stirring. After cooling to 50 ° C., the C component was added and further stirred and mixed to prepare an emulsion.
【0027】 実施例3 ローション [成分] 部 製造例3の抽出物溶液 5.0 エタノール 10.0 グリセリン 3.0 1、3−ブチレングリコール 2.0 メチルパラベン 0.2 クエン酸 0.1 クエン酸ナトリウム 0.3 カルボキシビニルポリマー 0.1 香料 適量 精製水 全量が100部となる量 上記の成分を混合してローションを調製した。Example 3 Lotion [Component] Part Extract solution of Production Example 3 5.0 Ethanol 10.0 Glycerin 3.0 1,3-butylene glycol 2.0 Methylparaben 0.2 Citric acid 0.1 Sodium citrate 0.3 Carboxyvinyl polymer 0.1 Appropriate amount of perfume Purified water An amount that gives a total amount of 100 parts The above components were mixed to prepare a lotion.
【0028】 実施例4 パック [成分] 部 ポリビニルアルコール 15.0 ヒドロキシメチルセルロース 5.0 プロピレングリコール 5.0 エタノール 10.0 メチルパラベン 0.2 製造例4の抽出物溶液 5.0 香料 適量 精製水 全量が100部となる量 上記の成分を混合してパックを調製した。Example 4 Pack [Ingredients] Part Polyvinyl alcohol 15.0 Hydroxymethylcellulose 5.0 Propylene glycol 5.0 Ethanol 10.0 Methylparaben 0.2 Extract solution of Production Example 4 5.0 Perfume Appropriate amount Purified water A pack was prepared by mixing the above components with 100 parts.
【0029】 実施例5 プレスパウダー [A成分] 部 ベンガラ 0.5 黄酸化鉄 1.5 黒酸化鉄 0.1 酸化チタン 10.0 ナイロンパウダー 4.0 セリサイト 全量が100部となる量 マイカ 23.0 タルク 25.0 製造例5の抽出物粉末 0.2 [B成分] スクワラン 1.0 メチルポリシロキサン 4.0 プロピルパラベン 0.1 デヒドロ酢酸 0.1 流動パラフィン 2.0 香料 適量 上記のA成分とB成分をそれぞれ混合攪拌し混合した
後、200メッシュのタイラーメッシュの篩にかけ、得
られた混合粉末を金型に打型して均一なプレスパウダー
を調製した。Example 5 Press Powder [Component A] Part Bengala 0.5 Yellow Iron Oxide 1.5 Black Iron Oxide 0.1 Titanium Oxide 10.0 Nylon Powder 4.0 Sericite Amount of 100 parts of Mica 23 0.0 Talc 25.0 Extract powder of Production Example 5 0.2 [Component B] Squalane 1.0 Methylpolysiloxane 4.0 Propylparaben 0.1 Dehydroacetic acid 0.1 Liquid paraffin 2.0 Perfume Appropriate A The component and the component B were mixed and stirred, respectively, and then sieved through a 200 mesh Tyler mesh sieve, and the obtained mixed powder was pressed into a mold to prepare a uniform press powder.
【0030】 実施例6 浴剤 [成分] 部 製造例5の抽出物粉末 0.5 硫酸ナトリウム 47.0 炭酸水素ナトリウム 全量が100部となる量 香料 適量 上記の成分を混合攪拌して均一な浴剤を調製した。Example 6 Bath Agent [Components] Part Extract powder of Production Example 5 0.5 Sodium sulfate 47.0 Sodium hydrogen carbonate Amount that total amount becomes 100 parts Perfume Appropriate amount The above components are mixed and stirred to obtain a uniform bath. An agent was prepared.
【0031】比較例 クリーム 実施例1に於いて、製造例1のタコノキ属植物抽出物溶
液5.0部に代えて、コウジ酸1.0部を用いるほかは
実施例1と同様にしてクリームを調製した。Comparative Example Cream A cream was prepared in the same manner as in Example 1 except that 1.0 part of kojic acid was used in place of 5.0 parts of the extract of the plant belonging to the genus Octopus in Production Example 1. Prepared.
【0032】対照例 クリーム 実施例1に於いて、製造例1のタコノキ属植物抽出物溶
液を用いないほかは実施例1と同様にしてクリームを調
製した。Comparative Example Cream A cream was prepared in the same manner as in Example 1 except that the extract of the plant of the genus Octopus was not used.
【0033】試験例1 細胞内チロシナーゼ活性抑制作
用 [試験方法]培養B16マウスメラノーマ細胞を、96
穴マイクロプレートに1×104個/穴播種し、10%
仔牛血清(FBS)含有イーグル最少必須培地(ME
M)中、37℃、5%CO2の条件下に1日間プレ培養
した後、培養液を、製造例1の抽出物溶液を2.5又は
5.0%の濃度となるように添加した10%FBS含有
イーグルMEMで置換し、同条件で2日間培養した。次
に培養液を除去し、界面活性剤(TritonX−10
0)を添加した細胞処理液に、5mMのL−ドーパ又は
0.2%のMTTを添加して37℃でチロシナーゼ反応
を行った後、マイクロプレートリーダー(Model1
450、バイオラッド社製)を用い、波長490nmで
ドーパ値を、又570−630nmでMTT値をそれぞ
れ測定した。なお、比較のため、製造例1の抽出物溶液
の代わりに、2mMのコウジ酸を添加した場合及び試料
無添加の場合(ブランク)についても、同様の試験を行
った。Test Example 1 Inhibitory Effect of Intracellular Tyrosinase Activity [Test Method] Cultured B16 mouse melanoma cells were
1 × 104 / well seeded in a well microplate, 10%
Eagle minimum essential medium containing calf serum (FBS) (ME
After pre-culturing for 1 day in M) at 37 ° C. and 5% CO 2, the culture solution was added so that the extract solution of Production Example 1 had a concentration of 2.5 or 5.0%. The cells were replaced with Eagle MEM containing% FBS and cultured under the same conditions for 2 days. Next, the culture solution is removed, and a surfactant (Triton X-10) is removed.
0) was added to the cell treatment solution, 5 mM L-dopa or 0.2% MTT was added, and a tyrosinase reaction was performed at 37 ° C., followed by a microplate reader (Model 1).
450, manufactured by Bio-Rad Inc.), and the dopa value was measured at a wavelength of 490 nm, and the MTT value was measured at 570-630 nm. For comparison, the same test was performed for the case where 2 mM kojic acid was added instead of the extract solution of Production Example 1 and the case where no sample was added (blank).
【0034】[結果]上記の試験で得られたドーパ値を
図1に、又MTT値を図2に示した。図1及び図2の結
果から、本発明のタコノキ属植物抽出物が、細胞活性の
低下を伴うことなく、細胞内チロシナーゼ活性を有意に
抑制することが判る。[Results] The dopa value obtained in the above test is shown in FIG. 1, and the MTT value is shown in FIG. From the results of FIGS. 1 and 2, it can be seen that the extract of the plant of the genus Octopus according to the present invention significantly suppresses intracellular tyrosinase activity without a decrease in cell activity.
【0035】試験例2 色素沈着抑制試験 本発明のタコノキ属植物抽出物のin vivo美白作
用を、モルモットを用いた色素沈着抑制試験により評価
した。 [試験方法]有色モルモット(雄、8週齢)の背部中央
部のタテ60mm×ヨコ30mmの体毛を剃毛し、該部
分を左右二つに区画した。この区画の一方に製造例1の
抽出物溶液を精製水で希釈して濃度5.0%とした液
(試料溶液)を、他方に対照として精製水を、それぞれ
朝、夕各1回5mlずつ6日間塗布すると共に、該塗布
部位に毎日1回朝の塗布直前に500mJ/cm2のU
V−Bを照射し、6日目の夕方に照射部位の色素沈着の
状態を目視により観察し、以下の基準により評価した。Test Example 2 Pigmentation Inhibition Test The in vivo whitening effect of an extract of the plant of the genus Octopus according to the present invention was evaluated by a pigmentation inhibition test using guinea pigs. [Test Method] The hair of a colored guinea pig (male, 8 weeks of age) at the center of the back at 60 mm in the vertical direction and 30 mm in the horizontal direction was shaved, and this part was divided into two right and left parts. A liquid (sample solution) obtained by diluting the extract solution of Preparation Example 1 with purified water to a concentration of 5.0% in one of the compartments, and purified water as a control in the other, 5 ml each in the morning and evening, respectively. Apply for 6 days, and apply 500 mJ / cm 2 of U to the application site once daily immediately before application in the morning.
The sample was irradiated with VB, and the state of pigmentation at the irradiated site was visually observed on the evening of the sixth day, and evaluated according to the following criteria.
【0036】[色素沈着の評価基準] − : 色素沈着を認めない ± : 軽微な色素沈着を認める + : 軽度な色素沈着を認める 2+ : 中程度の色素沈着を認める 3+ : 重度な色素沈着を認める[Evaluation Criteria for Pigmentation]-: No pigmentation observed ±: Slight pigmentation observed +: Mild pigmentation observed 2+: Moderate pigmentation observed 3+: Severe pigmentation observed
【0037】[結果]結果を表1に示す。[Results] The results are shown in Table 1.
【表1】 [Table 1]
【0038】表1の結果から明らかな通り、本発明のタ
コノキ属植物抽出物は、紫外線暴露に基づく皮膚への色
素沈着を顕著に抑止する効果を有する。 試験例3 皮膚刺激性評価試験 眼粘膜刺激性試験の代替法である培養ウサギ角膜細胞
(SIRC)を用いたニュートラルレッド取り込み試験
により、各種美白成分の皮膚刺激性を評価した。As is clear from the results shown in Table 1, the extract of the genus Octopus according to the present invention has an effect of remarkably inhibiting pigmentation on the skin due to exposure to ultraviolet rays. Test Example 3 Skin irritation evaluation test The skin irritation of various whitening ingredients was evaluated by a neutral red uptake test using cultured rabbit corneal cells (SIRC), which is an alternative method to the ocular mucosal irritation test.
【0039】[試料] (1)製造例5の抽出物粉末 (2)コウジ酸 (3)アルブチン[Samples] (1) Extract powder of Production Example 5 (2) Kojic acid (3) Arbutin
【0040】[試験方法]SIRCを96穴マイクロプ
レートに5000個/穴播種し、5%仔牛血清含有イー
グル最少必須培地(MEM)で3日間培養した後、これ
に試料を0.2%の濃度となるように添加し、さらに2
日間培養した。次に、SIRCを0.05%ニュートラ
ルレッド(NR)含有イーグルMEM培地で3時間培養
し、ここに得られたSRICについてNRの取り込み率
を求め、その値から各試料の皮膚刺激性を評価した。[Test Method] SIRC was seeded at 5,000 cells / well in a 96-well microplate, and cultured in Eagle's minimum essential medium (MEM) containing 5% calf serum for 3 days. And then add 2
Cultured for days. Next, SIRC was cultured in an Eagle MEM medium containing 0.05% neutral red (NR) for 3 hours, the NR uptake rate was determined for the obtained SRIC, and the skin irritation of each sample was evaluated from the value. .
【0041】[結果]結果を表2に示す。[Results] The results are shown in Table 2.
【表2】 [Table 2]
【0042】表2に示す通り、本発明のタコノキ属植物
抽出物は、既存の美白剤に比べて皮膚に対する刺激性が
少なく、安全性にすぐれた化粧料を提供することが可能
である。As shown in Table 2, the extract of the plant of the genus Octopus according to the present invention is less irritating to the skin than existing whitening agents, and can provide cosmetics excellent in safety.
【0043】試験例4 モニターテスト 実施例1、比較例及び対照例の各クリームについて、モ
ニターテストにより皮膚色素沈着に対する抑制効果並び
に皮膚刺激性を調べた。 [試験方法]無作為に抽出した年齢18〜50歳の女性
20名を被験者とし、各クリームを1日2回(朝、
晩)、1ヵ月間左上腕部にそれぞれ塗布し、塗布部の色
素沈着の状態及び皮膚の紅斑を目視で観察し、以下の評
価基準に基づいて評価した。Test Example 4 Monitor Test Each of the creams of Example 1, Comparative Example and Control Example was subjected to a monitor test to examine its inhibitory effect on skin pigmentation and skin irritation. [Test method] Twenty women aged 18 to 50 years randomly selected as subjects were given each cream twice a day (morning,
Night), and applied to the left upper arm for one month, the state of pigmentation of the applied part and the erythema of the skin were visually observed, and evaluated based on the following evaluation criteria.
【0044】[評価基準] (色素沈着) A:なくなった B:明らかに少なくなった C:いくらか少なくなった D:殆ど変化がなかった E:かえって多くなった (紅斑) A:対照例と差がない B:対照例と殆ど差がない C:対照例に比べて多少紅斑が目立つ D:対照例に比べて相当紅斑が目立つ E:対照例に比べて明らかに紅斑が目立つ[Evaluation Criteria] (Pigmentation) A: disappeared B: apparently decreased C: somewhat decreased D: hardly changed E: increased rather (erythema) A: difference from control No: B: almost no difference from control example C: erythema is slightly more noticeable than control example D: considerable erythema is more noticeable than control example E: erythema is clearly noticeable compared to control example
【0045】[結果]結果を表3に示す。[Results] The results are shown in Table 3.
【0046】[0046]
【表3】 [Table 3]
【0047】表3に示す通り、本発明のタコノキ属植物
抽出物を配合したクリームは、すぐれた色素沈着防止効
果を具え、しかも皮膚に対する刺激が少なく安全性が高
い。As shown in Table 3, the cream containing the plant extract of the genus Octopus according to the present invention has an excellent effect of preventing pigmentation, and is highly safe with little irritation to the skin.
【0048】[0048]
【発明の効果】タコノキ科タコノキ属に属する植物の抽
出物を配合してなる本発明の化粧料は、有効成分の上記
抽出物の有する強いチロシナーゼ活性抑制作用により、
シミ、ソバカスなど皮膚の色素沈着を顕著に抑制或は軽
減すると共に、該抽出物が天然物由来のものであるため
皮膚に対する刺激が少なく安全性にすぐれている。Industrial Applicability The cosmetic of the present invention comprising an extract of a plant belonging to the genus Taconium of the octopus family has a strong tyrosinase activity inhibitory action of the extract of the active ingredient.
Not only does it significantly suppress or reduce pigmentation of the skin such as spots and freckles, and since the extract is derived from natural products, it is less irritating to the skin and is excellent in safety.
【図1】図1は、試験例1の各試料のドーパ値を示すグ
ラフである(縦軸:ドーパ値)。FIG. 1 is a graph showing the dopa value of each sample of Test Example 1 (vertical axis: dopa value).
【図2】図2は、試験例1の各試料のMTT値を示すグ
ラフである(縦軸:MTT値)。FIG. 2 is a graph showing the MTT value of each sample of Test Example 1 (vertical axis: MTT value).
───────────────────────────────────────────────────── フロントページの続き (72)発明者 羽田容介 大阪市西区北堀江1丁目6番8号共栄化学 工業株式会社内 Fターム(参考) 4C083 AA111 AA112 AA122 AB232 AB242 AB312 AB352 AB432 AB442 AC012 AC022 AC102 AC122 AC302 AC392 AC422 AC442 AC482 AC842 AD072 AD112 AD152 AD272 AD332 AD572 CC04 CC05 CC07 CC25 DD17 DD31 EE16 ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Yosuke Haneda 1-6-8 Kitahorie, Nishi-ku, Osaka Kyoei Chemical Industry Co., Ltd. F-term (reference) 4C083 AA111 AA112 AA122 AB232 AB242 AB312 AB352 AB432 AB442 AC012 AC022 AC102 AC122 AC302 AC392 AC422 AC442 AC482 AC842 AD072 AD112 AD152 AD272 AD332 AD572 CC04 CC05 CC07 CC25 DD17 DD31 EE16
Claims (2)
出物を配合したことを特徴とする化粧料。1. A cosmetic comprising an extract of a plant belonging to the genus Taconium of the family Taconidae.
ンダヌス・アマリリフォリウス(Pandanus amaryllifol
ius Roxb.)である請求項1に記載の化粧料。2. The plant belonging to the genus Taconidaceae belonging to the octopus family Pandanus amaryllifol (Pandanus amaryllifol).
ius Roxb.).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000312429A JP4445658B2 (en) | 2000-10-12 | 2000-10-12 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000312429A JP4445658B2 (en) | 2000-10-12 | 2000-10-12 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002121110A true JP2002121110A (en) | 2002-04-23 |
| JP4445658B2 JP4445658B2 (en) | 2010-04-07 |
Family
ID=18792022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000312429A Expired - Fee Related JP4445658B2 (en) | 2000-10-12 | 2000-10-12 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4445658B2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6978015B1 (en) * | 2020-06-29 | 2021-12-08 | 徹 中西 | Composition for skin application to increase the expression of CCN1 and CCN2 |
| CN114403435A (en) * | 2022-01-25 | 2022-04-29 | 中国热带农业科学院橡胶研究所 | Preparation method and application of gorgeous powder |
| CN115919722A (en) * | 2022-08-26 | 2023-04-07 | 广东芭薇生物科技股份有限公司 | A kind of extract of Pandanus leaves and its preparation method and application |
| CN117959228A (en) * | 2024-03-28 | 2024-05-03 | 威莱(广州)日用品有限公司 | Anti-dandruff and anti-hair-loss shampoo containing natural plant components and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL443004A1 (en) | 2022-11-30 | 2024-06-03 | Pbclabs Spółka Z Ograniczoną Odpowiedzialnością | Extract of flowers, leaves and/or seed capsules of impatiens (Impatiens) and pandan leaves (Pandanus), in dry and liquid form, method of its preparation and its use |
-
2000
- 2000-10-12 JP JP2000312429A patent/JP4445658B2/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6978015B1 (en) * | 2020-06-29 | 2021-12-08 | 徹 中西 | Composition for skin application to increase the expression of CCN1 and CCN2 |
| JP2022022590A (en) * | 2020-06-29 | 2022-02-07 | 徹 中西 | Composition for application to skin to increase expression of ccn1 and ccn2 |
| CN114403435A (en) * | 2022-01-25 | 2022-04-29 | 中国热带农业科学院橡胶研究所 | Preparation method and application of gorgeous powder |
| CN114403435B (en) * | 2022-01-25 | 2023-09-19 | 中国热带农业科学院橡胶研究所 | Preparation method and application of Banlan powder |
| CN115919722A (en) * | 2022-08-26 | 2023-04-07 | 广东芭薇生物科技股份有限公司 | A kind of extract of Pandanus leaves and its preparation method and application |
| CN117959228A (en) * | 2024-03-28 | 2024-05-03 | 威莱(广州)日用品有限公司 | Anti-dandruff and anti-hair-loss shampoo containing natural plant components and preparation method thereof |
| CN117959228B (en) * | 2024-03-28 | 2024-06-11 | 威莱(广州)日用品有限公司 | Anti-dandruff and anti-hair-loss shampoo containing natural plant components and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4445658B2 (en) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7700123B2 (en) | Cosmetics | |
| JP3601875B2 (en) | Cosmetics | |
| JP4495925B2 (en) | Collagen and elastin production promoter and anti-aging cosmetic containing the same | |
| JP2011225564A (en) | Cosmetic | |
| JP4592911B2 (en) | Cosmetics | |
| JP6510744B2 (en) | Cosmetics | |
| JP3846680B2 (en) | Cosmetics | |
| JP4424561B2 (en) | Whitening cosmetics | |
| JP4445658B2 (en) | Cosmetics | |
| JP5177827B2 (en) | Topical skin preparation | |
| JP3987733B2 (en) | Fibroblast activator and skin external preparation containing the same | |
| JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
| JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP4621958B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP5175411B2 (en) | Cosmetics | |
| JP5057638B2 (en) | Topical skin preparation | |
| JP6725203B2 (en) | Cosmetics | |
| JPH0952817A (en) | Whitening cosmetics | |
| JP2003012449A (en) | Cosmetics | |
| JP2004262894A (en) | Skin/hair protecting agent and cosmetic containing the same | |
| JP2000351722A (en) | Skin cosmetic | |
| JP2019182819A (en) | Antioxidant, and cosmetic | |
| JP4028837B2 (en) | Cosmetics | |
| JP2023134261A (en) | Carbonylation inhibitors and cytokine production inhibitors | |
| JP2005320308A (en) | Enzyme-treated decomposition product and cosmetics containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071001 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090819 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090915 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091116 |
|
| TRDD | Decision of grant or rejection written | ||
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091116 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100105 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100118 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130122 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160122 Year of fee payment: 6 |
|
| LAPS | Cancellation because of no payment of annual fees |